128 results
424B3
XRTX
XORTX Therapeutics Inc
13 Jun 24
Prospectus supplement
4:19pm
, suspensions or termination of clinical trials by the applicable institutional review board or independent ethics board responsible for overseeing the study
424B3
XRTX
XORTX Therapeutics Inc
13 Jun 24
Prospectus supplement
4:18pm
information is reliable, such internal research and management’s estimates have not been verified by any independent sources and the Company has … that are not “emerging growth companies,” including, but not limited to, not being required to have our independent registered public accounting firm audit our internal
424B3
XRTX
XORTX Therapeutics Inc
13 Jun 24
Prospectus supplement
4:17pm
independent accountants satisfactory to the Manager forthwith to furnish the Manager a letter, and (2) the Chief Financial Officer of the Company … satisfactory to the Manager, confirming that they are independent accountants within the meaning of the Securities Act and the Exchange Act
424B3
XRTX
XORTX Therapeutics Inc
13 Jun 24
Prospectus supplement
4:15pm
or terminate a study; delays, suspensions or termination of clinical trials by the applicable institutional review board or independent ethics board
424B3
XRTX
XORTX Therapeutics Inc
13 Jun 24
Prospectus supplement
4:12pm
, suspensions or termination of clinical trials by the applicable institutional review board or independent ethics board responsible for overseeing the study
424B3
zorpd
13 Jun 24
Prospectus supplement
4:11pm
424B3
0s7cqnq8bec3
13 Jun 24
Prospectus supplement
4:10pm
424B3
1t4si q832q0tif
13 Jun 24
Prospectus supplement
4:10pm
6-K
EX-99.2
yl7dms
16 May 24
Condensed Interim Consolidated Financial Statements
6:45pm
6-K
EX-99.1
pu6nkkapgxvzrcxs
22 Apr 24
XORTX Announces Publication of Key Research in ADPKD
7:00am
6-K
EX-10.1
yi38f
30 Nov 23
XORTX Announces US ATM Offering
4:04pm
424B5
29k5q4 xv
29 Nov 23
Prospectus supplement for primary offering
9:57pm
6-K
EX-99.2
07jsngrahitwj3
15 Nov 23
Condensed Interim Consolidated Financial Statements
9:30pm
6-K
EX-99.1
99rwp9jqvo38ez1
2 Nov 23
XORTX Sponsored Study Presented at the American Society of Nephrology – Kidney Week 2023
7:00am